Masonic Cancer Center, University of Minnesota
Cancer Center Program Meetings
Grant Information and Announcements
Tuesday, February 27, 2007, 12-1 p.m., 450 CCRB
Oncogenes and tumor supressors—the good, the bad and the downright ugly
Gerard Evan, Ph.D., FRS Gerson and Barbara Bass Bakar Distinguished Professor of Cancer Research, Cancer Research Institute and Department of Cellular and Molecular Pharmacology, UCSF Comprehensive Cancer Center
Host: Perry Hackett, Ph.D.
A peek at next week's seminar:
Tuesday, March 6, 2006, 12-1 p.m., 450 CCRB
Signaling networks of telomere and stress-induced cellular aging
John M. Sedivy, Ph.D., Herman C. Bumpus Professor of Biology, Professor of Medical Science, Chair, Departments of Moledular Bioliogy, Cell Biology and Biochemistry, Brown University
Host: Eric Hendrickson, Ph.D.
For a complete schedule visit the Masonic Cancer Center Web site Seminar Series listing.
Despite the building snowstorm Saturday afternoon, about 250 people visited the Masonic Cancer Center's seventh annual Cancer and the Human Body exhibit at the Science Museum of Minnesota in St. Paul. Visitors of all ages learned about cancer and current research being done at the University. Visit the Masonic Cancer Center Web site to see photos from the event.
Thank you to the following researchers, students, and staff for participating: Noelle Blue Arm, M.D.; Marva Bohen, M.S., R.N.; Sue Carver, R.N.; Sharon Donnelly; Stephen Ekker, Ph.D.; Dan Heieren; Charleen Pagel Jue; Teri Kast, M.S., R.N.; Gina Kennedy; Bailey Lee; Sarah Nakib; Chris Pennell, Ph.D.; Sandra Rivera; Anthony-Osei Safo, M.D.; Sarah Schram, M.D.; Justin Seningen, M.D.; Justin Seroy; David Tasso, M.D.; Erin Warshaw, M.D.; Madeline Warshaw; Stephanie Westcot; and Sierra Zellmer.
Wednesday, February 28, 2007, 12-1 p.m., 5-122 MCB
Mary Grosse, Van Ness lab, will present the journal article "NF-KB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF" by Park et al., Nature Medicine 2006;13:62-69.
The Cancer Biology Journal Club is held every Wednesday. A complete schedule is available at the MICaB Web site. For more information contact: Sonja Johnson (john4368@umn.edu) or Rachel Bergerson (sapl0005@umn.edu).
Wednesday, February 28, 2007, 4 p.m., 450 CCRB
Anthracycline Induced Cardiotoxicity
Angie Smith, M.D., Fellow, Pediatric Hematology/Oncology/BMT
Thursday, March 1, 2007, 3:30 p.m., 2-580 Moos Tower
LexGrid: Tackling semantic interoperability in cancer-related clinical and translational science
Christopher Chute, M.D., Dr.P.H., Professor, Medical Informatics, Mayo College of Medicine
Friday, March 2, 2007, 1-2 p.m., 3-125 Mayo
Deregulated control of Rb/E2F-induced proliferation and apoptosis in cancer
Timothy C. Hallstrom, Ph.D., Duke Institute for Genome Sciences and Policy, Durham, North Carolina
Dr. Hallstrom is a faculty candidate in molecular oncology for the Department of Pediatrics. For more information contact Arlys Clements, 612-626-2961.
Friday, March 2, 2007, 1:15 p.m.-2:15 p.m., 450 CCRB
Tobacco carcinogens: implications for science and policy
Stephen Hecht, Ph.D., Wallin Chair in Cancer Prevention and Professor of Laboratory Medicine and Pathology, American Cancer Society Research Professor, Masonic Cancer Center
The Eighth Annual Spring Poster Session and Symposium sponsored by the Masonic Cancer Center Core Facilities will be held Wednesday, May 16, 2007, 11 a.m.-1:30 p.m. The schedule for the event includes oral presentations from 11 a.m. to noon followed by a poster session and lunch from noon to 1:30 p.m. Students, staff, postdocs and PIs are invited to participate by presenting a poster. The research presented in the poster must include the use of a Cancer Center Cores Facility.
Online registration will open on Monday, April 2, 2007 with a final deadline of April 27, 2007. Due to the increasing number (and size!) of posters and the limited amount of display space, we have decided to display the first 35 abstracts/posters that are submitted in the Masonic Cancer Center atrium areas. Other posters will be displayed as space permits in other areas of the Masonic Cancer Center. All abstracts will be printed in a program booklet.
For more information, call Sabine Fritz at 4-7151 or send an email to fritz017@umn.edu.
Thursday, April 5, 2007, 8:30 a.m.-4:30 p.m., Holiday Inn Metrodome, West Bank campus
This popular day-long workshop is open to AHC faculty and research staff currently involved in clinical and translational research. The workshop leader is David Morrison (Ph.D., Yale, Molecular Biology and Biophysics; Postdoctoral research fellow, National Institutes of Health and Scripps Research Institute). Dr. Morrison, a successful grant writer and co-founder of Grant Writers' Seminars and Workshops, L.L.C., will offer detailed guidance on all aspects of grant writing, focusing on the NIH (with supplementary information on the NSF).
For more information and to register visit the Office of Clinical Research Web site.
Friday, March 2, 2007, 12-1 p.m., 450 CCRB
Effects of menthol on smoking cessation
Kola Okuyemi, M.D, M.P.H, Director, Program in Health Disparities Research, Center for Clinical Research, Associate Professor, Department of Family Medicine and Community Health, University of Minnesota
For a complete schedule visit the Web site.
Friday, March 2, 2007, 450 CCRB
Tracking the endogenous CD4+ T cell memory response
Marion Pepper-Pew, Ph.D., Jenkins Lab
For a complete schedule visit the Web site.
Monday, March 5, 2007, 1:15-2:15 p.m., 450 CCRB
TBA
Mukta Arora, M.D., Assistant Professor, Department of Medicine, Division of HOT, University of Minnesota
For a complete schedule visit the Web site.
NIH Continuing Resolution Approved
(from NCI Cancer Bulletin, February 20, 2007)
On February 14, the FY 2007 Continuing Appropriations Resolution was passed by the Senate; it was signed into law by President Bush on February 15. NIH received a total appropriation of $28.9 billion, an increase of $619.5 million (2 percent) more than the FY 2006 appropriation. A large portion of this increase - $483 million - goes toward funding the NIH common fund.
Although NCI will continue to be funded at the FY 2006 level of $4.79 billion, NCI and other institutes will not be required to contribute to the common fund this year, which could translate into approximately $42.8 million for NCI.
Implementation of NIH Fiscal Policy for Non-Competing Grant Awards—FY 2007To implement the FY 2007 fiscal guidance, non-competing research awards will be awarded at 97.1% of the FY 2007 committed level. Future year commitments also will be adjusted accordingly. Institutes and centers (ICs) will maintain the flexibility to supplement such non-competing awards on a case-by-case basis according to scientific and programmatic imperatives. However, such supplements will not be considered as part of the base for future budgetary adjustments.
Non-competing awards previously issued in FY 2007 at reduced levels will be revised to restore funds to the level indicated above. This policy does not apply to Career Awards, SBIR/STTRs, and Ruth L. Kirschstein-National Research Service Award (NRSA) Individual Fellowships & Institutional Training Grants.
Comprehensive Minority Institution/Cancer Center Partnership (U54)
National Cancer Institute
Application Receipt Date(s): April 13, 2007
Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership (P20)
National Cancer Institute
Application Receipt/Submission Date(s): April 15, 2009
Academic Health Center Translational Research Grant Program
The Academic Health Center Translational Research Grant Program will fund three new grants with up to $200,000 over two to three years. Awards will go to new projects without outside funding and preference will go to projects that create new collaborations. The goal is to move concepts developed at the University from basic work to clinical testing. The deadline for receipt of applications is May 18. Awards will be announced in July. For program and application details, go to the Academic Health Center Web site.
This grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes genetic mechanisms of cancer, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic models and translational research, cancer immunology and immunotherapy. Funding is available up to $30,000. Applications may be obtained by contacting LeAnn Micek, 612-626-1926, micek003@ umn.edu.